Automated Pain Intervention for Underserved Minority Breast Cancer Patients
Completed
- Conditions
- Breast Cancer
- Interventions
- Behavioral: QuestionnairesBehavioral: Telephone Intervention
- First Posted Date
- 2009-04-14
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00881010
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
Phase 1
Completed
- Conditions
- Follicular LymphomaMantle Cell LymphomaCD20 PositiveChronic Lymphocytic LeukemiaMarginal Zone LymphomaRecurrent Diffuse Large B-Cell LymphomaT-Cell Non-Hodgkin Lymphoma
- Interventions
- Procedure: Allogeneic Hematopoietic Stem Cell TransplantationBiological: Anti-Thymocyte GlobulinBiological: FilgrastimBiological: Rituximab
- First Posted Date
- 2009-04-14
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT00880815
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies
Phase 1
Completed
- Conditions
- Malignant Neoplasm
- Interventions
- Other: Laboratory Biomarker AnalysisProcedure: Positron Emission Tomography
- First Posted Date
- 2009-04-13
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00880074
- Locations
- πΊπΈ
M D Anderson Cancer Center, Houston, Texas, United States
Prostate Conformal Cryotherapy
Not Applicable
Completed
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Cryoablation
- First Posted Date
- 2009-04-08
- Last Posted Date
- 2018-01-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 48
- Registration Number
- NCT00877682
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Patient-Reported Outcomes (PRO)-Based Palliative and Hospice Care Practice: A Qualitative Study
Completed
- Conditions
- Advanced Cancer
- Interventions
- Behavioral: Interview
- First Posted Date
- 2009-04-08
- Last Posted Date
- 2011-09-21
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT00878267
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Quality of Life in Men With High Risk Localized Prostate Cancer
Withdrawn
- Conditions
- Prostate Cancer
- Interventions
- Behavioral: QOL Questionnaire
- First Posted Date
- 2009-04-08
- Last Posted Date
- 2012-07-30
- Lead Sponsor
- M.D. Anderson Cancer Center
- Registration Number
- NCT00877617
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
- First Posted Date
- 2009-04-08
- Last Posted Date
- 2016-08-25
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 44
- Registration Number
- NCT00877773
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy
Phase 2
Active, not recruiting
- Conditions
- Invasive Breast CarcinomaBilateral Breast CarcinomaHER2/Neu Negative
- Interventions
- Other: Best Practice
- First Posted Date
- 2009-04-07
- Last Posted Date
- 2025-05-31
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 116
- Registration Number
- NCT00877500
- Locations
- πΊπΈ
Lyndon Baines Johnson General Hospital, Houston, Texas, United States
πΊπΈAdvocate Christ Medical Center, Oak Lawn, Illinois, United States
πΊπΈM D Anderson Cancer Center, Houston, Texas, United States
Fatigue, Sleep and Cytokines in Primary Brain Tumor (PBT) Patients
Completed
- Conditions
- Brain Cancer
- Interventions
- Behavioral: Questionnaire
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2015-01-09
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT00876499
- Locations
- πΊπΈ
UT MD Anderson Cancer Center, Houston, Texas, United States
BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets
- First Posted Date
- 2009-03-31
- Last Posted Date
- 2015-10-23
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 10
- Registration Number
- NCT00872157
- Locations
- πΊπΈ
University of Texas MD Anderson Cancer Center, Houston, Texas, United States